Application of Animal Models in Diabetic Cardiomyopathy
Diabetic heart disease is a growing and important public health risk. Apart from the risk of coronary artery disease or hypertension, diabetes mellitus (DM) is a well-known risk factor for heart failure in the form of diabetic cardiomyopathy (DiaCM). Currently, DiaCM is defined as myocardial dysfunc...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Diabetes Association
2021-03-01
|
Series: | Diabetes & Metabolism Journal |
Subjects: | |
Online Access: | http://www.e-dmj.org/upload/pdf/dmj-2020-0285.pdf |
id |
doaj-0043f149b06c4590a78fa8f410c7e6ae |
---|---|
record_format |
Article |
spelling |
doaj-0043f149b06c4590a78fa8f410c7e6ae2021-04-02T01:07:41ZengKorean Diabetes AssociationDiabetes & Metabolism Journal2233-60792233-60872021-03-0145212914510.4093/dmj.2020.02852538Application of Animal Models in Diabetic CardiomyopathyWang-Soo Lee0Jaetaek Kim1 Division of Cardiology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea Division of Endocrinology and Metabolism, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, KoreaDiabetic heart disease is a growing and important public health risk. Apart from the risk of coronary artery disease or hypertension, diabetes mellitus (DM) is a well-known risk factor for heart failure in the form of diabetic cardiomyopathy (DiaCM). Currently, DiaCM is defined as myocardial dysfunction in patients with DM in the absence of coronary artery disease and hypertension. The underlying pathomechanism of DiaCM is partially understood, but accumulating evidence suggests that metabolic derangements, oxidative stress, increased myocardial fibrosis and hypertrophy, inflammation, enhanced apoptosis, impaired intracellular calcium handling, activation of the renin-angiotensin-aldosterone system, mitochondrial dysfunction, and dysregulation of microRNAs, among other factors, are involved. Numerous animal models have been used to investigate the pathomechanisms of DiaCM. Despite some limitations, animal models for DiaCM have greatly advanced our understanding of pathomechanisms and have helped in the development of successful disease management strategies. In this review, we summarize the current pathomechanisms of DiaCM and provide animal models for DiaCM according to its pathomechanisms, which may contribute to broadening our understanding of the underlying mechanisms and facilitating the identification of possible new therapeutic targets.http://www.e-dmj.org/upload/pdf/dmj-2020-0285.pdfcardiomyopathiesdiabetes mellitusdisease models, animalheart failure |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Wang-Soo Lee Jaetaek Kim |
spellingShingle |
Wang-Soo Lee Jaetaek Kim Application of Animal Models in Diabetic Cardiomyopathy Diabetes & Metabolism Journal cardiomyopathies diabetes mellitus disease models, animal heart failure |
author_facet |
Wang-Soo Lee Jaetaek Kim |
author_sort |
Wang-Soo Lee |
title |
Application of Animal Models in Diabetic Cardiomyopathy |
title_short |
Application of Animal Models in Diabetic Cardiomyopathy |
title_full |
Application of Animal Models in Diabetic Cardiomyopathy |
title_fullStr |
Application of Animal Models in Diabetic Cardiomyopathy |
title_full_unstemmed |
Application of Animal Models in Diabetic Cardiomyopathy |
title_sort |
application of animal models in diabetic cardiomyopathy |
publisher |
Korean Diabetes Association |
series |
Diabetes & Metabolism Journal |
issn |
2233-6079 2233-6087 |
publishDate |
2021-03-01 |
description |
Diabetic heart disease is a growing and important public health risk. Apart from the risk of coronary artery disease or hypertension, diabetes mellitus (DM) is a well-known risk factor for heart failure in the form of diabetic cardiomyopathy (DiaCM). Currently, DiaCM is defined as myocardial dysfunction in patients with DM in the absence of coronary artery disease and hypertension. The underlying pathomechanism of DiaCM is partially understood, but accumulating evidence suggests that metabolic derangements, oxidative stress, increased myocardial fibrosis and hypertrophy, inflammation, enhanced apoptosis, impaired intracellular calcium handling, activation of the renin-angiotensin-aldosterone system, mitochondrial dysfunction, and dysregulation of microRNAs, among other factors, are involved. Numerous animal models have been used to investigate the pathomechanisms of DiaCM. Despite some limitations, animal models for DiaCM have greatly advanced our understanding of pathomechanisms and have helped in the development of successful disease management strategies. In this review, we summarize the current pathomechanisms of DiaCM and provide animal models for DiaCM according to its pathomechanisms, which may contribute to broadening our understanding of the underlying mechanisms and facilitating the identification of possible new therapeutic targets. |
topic |
cardiomyopathies diabetes mellitus disease models, animal heart failure |
url |
http://www.e-dmj.org/upload/pdf/dmj-2020-0285.pdf |
work_keys_str_mv |
AT wangsoolee applicationofanimalmodelsindiabeticcardiomyopathy AT jaetaekkim applicationofanimalmodelsindiabeticcardiomyopathy |
_version_ |
1724175260402581504 |